David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.89% |
| 2 | Technology | 10.04% |
| 3 | Healthcare | 9.38% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Elevance Health
ELV
$86.9B
| $63.2M | 0.09% |
385,309
-140,614
| -27% | -$22.5M |
|
252
Herbalife
HLF
$1.33B
| $63.2M | 0.09% |
2,295,950
-4,468
| -0.2% | -$108K |
|
253
Alcoa
AA
$13.7B
| $62.8M | 0.09% |
2,343,772
+943,265
| +67% | +$29.2M |
|
|
HZNP
254
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $62.7M | 0.09% |
1,805,525
+248,502
| +16% | +$7.58M |
|
255
MGM Resorts International
MGM
$11B
| $62.6M | 0.09% |
3,430,386
-1,286,357
| -27% | -$26.1M |
|
|
VMRK
256
Vivmark Residential
VMRK
$25B
| $62.5M | 0.09% |
891,234
+16,385
| +2% | +$1.22M |
|
257
NewMarket
NEU
$8.62B
| $61.7M | 0.09% |
138,970
-23,850
| -15% | -$11M |
|
258
PUT
Union Pacific
UNP
$183B
| $61.6M | 0.09% |
646,300
+260,000
| +67% | +$27.1M |
|
259
CVS Health
CVS
$119B
| $61.5M | 0.09% |
586,115
+111,434
| +23% | +$11.4M |
|
|
STRZA
260
DELISTED
Starz - Series A
STRZA
| $60.8M | 0.09% |
1,360,289
+263,239
| +24% | +$10.5M |
|
|
XLNX
261
DELISTED
Xilinx Inc
XLNX
| $60.8M | 0.09% |
1,377,106
+229,211
| +20% | +$10.3M |
|
262
Bank of America
BAC
$431B
| $60.7M | 0.09% |
3,564,594
-4,807,798
| -57% | -$79.2M |
|
|
263
Biogen
BIIB
$32B
| $60.4M | 0.09% |
149,509
-763,424
| -84% | -$306M |
|
|
PNK
264
DELISTED
Pinnacle Entertainment Inc.
PNK
| $60.3M | 0.09% |
1,616,353
-392,062
| -20% | -$14.4M |
|
265
Fidelity National Information Services
FIS
$21.3B
| $60.1M | 0.09% |
973,289
+181,147
| +23% | +$11.6M |
|
266
Kirby Corp
KEX
$7.39B
| $60M | 0.09% |
783,267
-207,638
| -21% | -$16.5M |
|
267
Home Depot
HD
$335B
| $59.7M | 0.09% |
537,136
+25,051
| +5% | +$2.8M |
|
|
MRC
268
DELISTED
MRC Global
MRC
| $59.5M | 0.09% |
3,853,276
+483,290
| +14% | +$7.3M |
|
269
PUT
Boeing
BA
$169B
| $59.4M | 0.09% |
428,100
+106,100
| +33% | +$15.5M |
|
270
Wynn Resorts
WYNN
$10.3B
| $59.1M | 0.09% |
599,467
+324,043
| +118% | +$36.6M |
|
271
PUT
Baidu
BIDU
$31.6B
| $59.1M | 0.09% |
296,900
+86,500
| +41% | +$17.7M |
|
|
ALXN
272
DELISTED
Alexion Pharmaceuticals
ALXN
| $59M | 0.09% |
326,566
+304,907
| +1,408% | +$52.6M |
|
273
PUT
Starbucks
SBUX
$122B
| $58.9M | 0.09% |
1,099,200
+420,000
| +62% | +$21.3M |
|
274
PUT
Regeneron Pharmaceuticals
REGN
$85.9B
| $58.7M | 0.09% |
115,000
+38,300
| +50% | +$18.7M |
|
|
MJN
275
DELISTED
Mead Johnson Nutrition Company
MJN
| $58.3M | 0.09% |
646,621
+625,479
| +2,958% | +$60.3M |
|
Similar funds
David Shaw's Q2 2015 Portfolio in Review
As of Q2 2015, David Shaw held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw's Q2 2015 filing shows 504 new, 1,541 increased, 1,229 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
- David Shaw's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- David Shaw added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- David Shaw's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- David Shaw fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- David Shaw's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- David Shaw opened 504 new positions and closed 364 in Q2 2015.
- David Shaw's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.